Previous lymphoma studies have reported that survivin overexpression, as detected by immunohistochemistry, is associated with poor clinical outcomes of DLBCL, especially ABC subtype DLBCL [17–19]. Here, BIRC5 is linked to diffuse large B-cell lymphoma.